why did fda stop tirzepatide FDA's Removal of Semaglutide and the Evolving Decisions: What Compounders Need to Know FDA Says Compounded Tirzepatide Must

Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al

Preclinical data strongly map these peptides to enhanced barrier function, mucosal proliferation, and local immunomodulation

ANZCA have also established a dedicated webpage for GLP-1 receptor agonists - clinical practice recommendations which includes links to: The guidance document Clinical Practice Recommendations regarding patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation for surgical and endoscopic procedures

Others may lose weight after the surgery, either because of changes in diet or due to digestive issues that make it hard to absorb fats